Working With FDA on a PMA Approval

Published on January 29, 2016
Categorized as Submissions

Appealing to a higher power

We assisted a client in negotiating with FDA the clinical trial endpoints, a diagnostic algorithm, inclusion and exclusion criteria, control, how to eliminate for bias, and a shortened follow-up period that saved the company two years and $32MM in additional cost (burn rate and out-of-pocket expense). We did it by elevating the matter to senior management for resolution.  We were able to do this while avoiding an FDA panel meeting.


The information on our site is not intended to provide specific legal advice.
Helping clients be appropriately aggressive, yet compliant. TM